Relationship of transforming growth factor-beta1 with tumour necrosis factor-alpha and endothelial activation in patients with stable renal transplantation

Nephrology

Volumn 13, Issue 2, 2008, Pages 164-170

  Palermo, Alessandro ^b   Mulè, Giuseppe ^b   Vadalà, Anna ^b   Vaccaro, Francesco ^b   Guarneri, Marco ^b   Arsena, Rosalia ^b   Briolotta, Chiara ^b   Cerasola, Giovanni ^b   Cottone, Santina ^a,b  

^a University of Palermo ^*  (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Adhesion molecule; Chronic renal insufficiency; Renal transplantation; Transforming growth factor beta; Tumour necrosis factor alpha

Indexed keywords

C REACTIVE PROTEIN; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CADAVER DONOR; CADAVER KIDNEY; CELL ADHESION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DISEASE MARKER; ENDOTHELIUM CELL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; REGRESSION ANALYSIS; STUDENT T TEST;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; GLOMERULAR FILTRATION RATE; GRAFT SURVIVAL; HUMANS; HYPERTENSION; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 38949161476     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00858.x     Document Type: Article

References (29)

1. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N. Engl. J. Med. 1999 341 : 1725 30.
2. Paul LC. Chronic allograft nephropathy: An update. Kidney Int. 1999 56 : 783 93.
3. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N. Engl. J. Med. 2003 349 : 2326 33.
4. Manjunath G, Tighiouart H, Ibrahim H et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcome in the community. J. Am. Coll. Cardiol. 2003 41 : 47 55.
5. Bakri RS, Afzali B, Covic A et al. Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation. Clin. Transplant 2004 18 : 201 4.
6. Varagunam M, Finney H, Trevitt R et al. Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients. Am. J. Kidney Dis. 2004 43 : 502 7.
7. Winkelmayer WC, Schaeffner ES, Chandraker A. A J-shaped association between high-sensitivity C-reactive protein and mortality in kidney transplant recipients. Transpl. Int. 2007 20 : 505 11.
8. Deanfield J, Donald A, Ferri C et al. Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension: Endothelial function and dysfunction. Part I. Methodological issues for assessment in the different vascular beds: A statement by the Working Group on Endothelin and endothelial factors of the European society of Hypertension. J. Hypertens 2005 23 : 7 17.
9. Wiggins MC, Bracher M, Mall A, Hickman R., Robson SC, Kahn D. Tumour necrosis factor levels during acute rejection and acute tubular necrosis in renal transplant recipients. Transpl. Immunol. 2000 8 : 211 5.
10. Al-Lamki RS, Wang J, Skepper JN, Thiru S, Pober JS, Bradley JR. Expression of tumor necrosis factors receptors in normal kidney and rejecting renal transplants. Lab. Invest. 2001 81 : 1503 15.
11. Cottone S, Palermo A, Vaccaro F, Vadalà A, Buscemi B, Cerasola G. Oxidative stress and inflammation in long-term renal transplanted hypertensives. Clin. Nephrol. 2006 66 : 32 8.
12. Cottone S, Palermo A, Vaccaro F et al. Inflammation and endothelial activation are linked to renal function in long-term kidney transplantation. Transpl. Int. 2007 20 : 82 7.
13. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N. Engl. J. Med. 1994 331 : 1286 92.
14. Cuhaci B, Kumar MS, Bloom RD et al. Transforming growth factor-beta levels in human allograft chronic fibrosis correlate with rate of decline in renal function. Transplantation 1999 68 : 785 90.
15. Shihab FS, Yamamoto T, Nast CC et al. Transforming growth factor-beta and matrix protein expression in acute and chronic rejection of human renal allografts. J. Am. Soc. Nephrol. 1995 6 : 286 94.
16. Baczkowska T, Perkowska-Ptasinska A, Sadowska A et al. Serum TGF-beta1 correlates with chronic histopathological lesions in protocol biopsies of kidney allograft recipients. Transplant. Proc. 2005 37 : 773 5.
17. Ozdemir BH, Ozdemir FN, Demirhan B, Haberal M. TGF-beta1 expression in renal allograft rejection and cyclosporine A toxicity. Transplantation 2005 80 : 1681 5.
18. Pribylova-Hribova P, Kotsch K, Lodererova A et al. TGF-beta1 mRNA upregulation influences chronic renal allograft dysfunction. Kidney Int. 2006 69 : 1872 9.
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate Glomerular Filtration Rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 1999 130 : 461 70.
20. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J. Hypertens 2003 21 : 1011 53.
21. De Kossodo S. WHO Collaborative Study Group: Assaying tumor necrosis factor concentration in human serum. A WHO International Collaborative Study. J. Immunol. Methods 1995 182 : 107 11.
22. Cottone S, Mulè G, Nardi E et al. Relation of C-reactive protein to oxidative stress and to endothelial activation in essential hypertension. Am. J. Hypertens 2006 19 : 313 8.
23. Campistol JM, Inigo P, Jimenez W et al. Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy. Kidney Int. 1999 56 : 714 9.
24. Citterio F, Pozzetto U, Romagnoli J et al. Plasma levels of transforming growth factor-beta1 in renal transplant recipients receiving different immunosuppressive regimens. Transplant. Proc. 2004 36 : 698 9.
25. Crews GM, Erickson L, Pan F et al. Down-regulation of TGF-beta and VCAM-1 is associated with successful treatment of chronic rejection in rats. Transplant. Proc. 2005 37 : 1926 8.
26. Oyen O, Wergeland R., Bentdal O, Hartmann A, Brekke IB, Stokke O. Serial ultrasensitive CRP measurements may be useful in rejection diagnosis after Kidney Transplantation. Transplant. Proc. 2001 33 : 2481 3.
27. Cueto-Manzano AM, Morales-Buenrostro LE, Gonzalez-Espinoza L et al. Markers of inflammation before and after Renal Transplantation. Transplantation 2005 80 : 47 51.
28. Cottone S, Mulè G, Amato F et al. Amplified biochemical activation of endothelial function in hypertension associated with moderate to severe renal failure. J. Nephrol. 2002 15 : 643 8.
29. Kasiske BL. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am. J. Med. 1988 84 : 985 92.